{{Rsnum
|rsid=12261764
|Chromosome=10
|Orientation=plus
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene=WDR11-AS1
|position=122522381
|Gene_s=WDR11-AS1
|Assembly=GRCh37.p10
|GenomeBuild=37.5
|dbSNPBuild=138
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 66.1 | 33.0 | 0.9
| HCB | 78.7 | 19.1 | 2.2
| JPT | 76.8 | 22.3 | 0.9
| YRI | 95.2 | 4.8 | 0.0
| ASW | 89.5 | 10.5 | 0.0
| CHB | 78.7 | 19.1 | 2.2
| CHD | 62.4 | 36.7 | 0.9
| GIH | 80.2 | 17.8 | 2.0
| LWK | 92.7 | 7.3 | 0.0
| MEX | 77.6 | 22.4 | 0.0
| MKK | 90.3 | 9.7 | 0.0
| TSI | 63.7 | 32.4 | 3.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=25140149
|Title=Genetic variation modifies risk for neurodegeneration based on biomarker status
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | Illumina Human 1M}}